Skip to main content

GSA CAPITAL PARTNERS LLP

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1362033 LONDON, X0

Position in ORIC

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$161,795
-$415,991 QoQ
Shares Held
12,770
-81.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ORIC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ORIC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $161,795 12,770
2025-12-31 $577,786 70,634
2025-09-30 $383,136 31,928
2025-03-31 $88,409 15,844
2023-12-31 $225,538 24,515
2023-09-30 $205,808 34,018
2023-06-30 $927,242 119,490
2023-03-31 $811,708 142,405
2022-12-31 $1,403,934 238,359
2022-09-30 $721,920 225,600
2022-06-30 $226,844 50,635
2022-03-31 $226,987 42,507
2021-12-31 $352,123 23,954